Cite
An L-type calcium channel blocker nimodipine exerts anti-fibrotic effects by attenuating TGF-β1 induced calcium response in an in vitro model of thyroid eye disease
MLA
Qian Chen, et al. “An L-Type Calcium Channel Blocker Nimodipine Exerts Anti-Fibrotic Effects by Attenuating TGF-Β1 Induced Calcium Response in an in Vitro Model of Thyroid Eye Disease.” Eye and Vision, vol. 11, no. 1, Sept. 2024, pp. 1–22. EBSCOhost, https://doi.org/10.1186/s40662-024-00401-5.
APA
Qian Chen, Yuan Pan, Yunwei Hu, Guanyu Chen, Xiaoqing Chen, Yanyan Xie, Minzhen Wang, Zhuang Li, Jun Huang, Yuxun Shi, Haixiang Huang, Te Zhang, Mei Wang, Peng Zeng, Sha Wang, Rongxin Chen, Yongxin Zheng, Liuxueying Zhong, Huasheng Yang, & Dan Liang. (2024). An L-type calcium channel blocker nimodipine exerts anti-fibrotic effects by attenuating TGF-β1 induced calcium response in an in vitro model of thyroid eye disease. Eye and Vision, 11(1), 1–22. https://doi.org/10.1186/s40662-024-00401-5
Chicago
Qian Chen, Yuan Pan, Yunwei Hu, Guanyu Chen, Xiaoqing Chen, Yanyan Xie, Minzhen Wang, et al. 2024. “An L-Type Calcium Channel Blocker Nimodipine Exerts Anti-Fibrotic Effects by Attenuating TGF-Β1 Induced Calcium Response in an in Vitro Model of Thyroid Eye Disease.” Eye and Vision 11 (1): 1–22. doi:10.1186/s40662-024-00401-5.